BioAsia 2023: Leaders from Novartis, Apple Talk Innovation, Tech, Data Privacy

BioAsia 2023 was a melting pot of ideas with Novartis's CEO and a senior executive from Apple, among others, discussing a range of topics including the potential of novel therapies and platforms such as siRNA and radioligand and also where things were headed as the union of technology and biotech drives new insights into biology and promises to help reimagine healthcare.

Tech, Biotech confluence discussed at BioAsia

Novartis AG CEO Vas Narasimhan set things rolling at the BioAsia conference in India with his keynote address that touched upon a range of topics including the potential of new therapies like small interfering RNA (siRNA) and radioligand, besides the sharp scale up over the years of the Swiss group’s operations in Hyderabad.

The CEO also spoke about his own Indian roots and the role of his grandparents and parents in opening up...